Form 4: Honeywell Executive Receives Equity Compensation

Honeywell International Inc. executive Kenneth J. West was granted Restricted Stock Units and Employee Stock Options under the company's 2016 Stock Incentive Plan.

Summary

• Kenneth J. West, President/CEO of Process Technologies at Honeywell International Inc. (HON), was granted equity awards on February 19, 2026.
• The awards include 4,668 Restricted Stock Units (RSUs) and 20,544 Employee Stock Options.
• The RSUs convert to common stock on a one-for-one basis and will vest 25% on each of February 19, 2027, February 19, 2028, February 19, 2029, and February 19, 2030.
• The Employee Stock Options have an exercise price of $240.99, vest on February 19, 2030, and expire on February 18, 2036.
• Both grants were made under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates.
• The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices that align management incentives with long-term shareholder value, without indicating any immediate operational or financial changes.

Positives

• The equity grants align the executive's long-term financial interests with those of shareholders, incentivizing sustained company performance.
• The use of a Rule 10b5-1(c) plan indicates a pre-arranged transaction, which is a standard practice for executives to manage equity holdings compliantly and reduces concerns about opportunistic trading.

Risks

• The ultimate value of the granted equity awards is directly dependent on the future market performance of Honeywell's common stock.
• The executive risks forfeiture of unvested awards if employment conditions are not met through the vesting periods.

Future Outlook

The multi-year vesting schedules for the equity awards indicate a long-term incentive structure designed to retain the executive and align their performance with the company's future success.

Industry Context

StockSavvy.ai notes that equity grants are a standard component of executive compensation packages across various industries, particularly in large, established companies like Honeywell, to incentivize long-term performance and retention. The specific terms, such as vesting schedules and exercise prices, are typically benchmarked against peer companies within the industrial technology sector.

Comparison to Industry Standards

• The grant of both Restricted Stock Units (RSUs) and Employee Stock Options (ESOs) is a common practice in executive compensation, similar to packages observed at peer companies such as General Electric (GE) or Siemens AG, which often use a mix of time-based and performance-based equity.
• The multi-year vesting schedule for RSUs (25% annually over four years) is consistent with typical industry standards designed to promote long-term retention and align executive interests with sustained shareholder value creation, mirroring practices at companies like Raytheon Technologies (RTX) or Johnson Controls (JCI).
• An exercise price for options set at the market price on the grant date ($240.99) is standard for incentive stock options, ensuring that the executive benefits only if the stock price appreciates from the grant date, a common feature in compensation plans across the S&P 500.

Stakeholder Impact

• Shareholders: The grants aim to align executive interests with long-term shareholder value creation, potentially leading to improved company performance.
• Employees: No direct impact on general employees, but it reflects the company's executive compensation strategy.

Next Steps

• The Restricted Stock Units will begin vesting on February 19, 2027, with subsequent vesting dates annually until February 19, 2030.
• The Employee Stock Options will vest on February 19, 2030, and can be exercised until their expiration on February 18, 2036.

Key Dates

Recommendation

This Form 4 filing details a routine equity compensation grant to an executive, which is an expected part of a public company's incentive structure. It does not provide new information that would fundamentally alter the investment thesis for Honeywell, nor does it signal any immediate operational or financial changes. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific compensation event.

Keywords

Honeywell, HON, Form 4, SEC Filing, Equity Grant, Restricted Stock Units, Stock Options, Executive Compensation, Insider Transaction, Kenneth J. West, 10b5-1 Plan